EPTS_CONCEPT_NAME,EPTS_CONCEPT_id,EPTS_CONCEPT_uuid,POC_CONCEPT_NAME,POC_CONCEPT_id,POC_CONCEPT_uuid
NOME CONFIDENTE,1740,,HOF_Other_Info_Provider,8338,c78e621a-31eb-4c6f-9580-2c12538c101c
PESSOA DE REFERENCIA - NUMERO DE TELEFONE,1611,,HOF_Other_Info_Contact,8339,a48ecbc9-2682-4347-85b7-e0f3c2d68316
TESTES ORDENADOS,1271,e25b13aa-1d5f-11e0-b929-000c29ad1d07,Type_of_test,7897,88438bbb-4e1b-4883-87c4-d027d6c1ebab
CARGA VIRAL,856,e25ffa50-1d5f-11e0-b929-000c29ad1d07,HOF_LAB_SITUATION_Carga_Viral_Absolute_Retrospective2,0,2d0b1667-5590-43a0-9b97-75d3124c50ad
CD4 %,730,"
",HOF_LAB_SITUATION_CD4_Percent2,0,2af10d4d-8ca3-4446-856f-3b313885560b
CD4 ABSOLUTO,5497,e24d0bca-1d5f-11e0-b929-000c29ad1d07,HOF_LAB_SITUATION_CD4_value2,0,95d48998-ccfd-4ec4-8099-5856bf592a72
HB.,21,e2619e78-1d5f-11e0-b929-000c29ad1d07,HOF_LAB_SITUATION_HB2,0,b687f14b-4440-417c-84c0-f24656e26b1c
ALT,654,e25e7964-1d5f-11e0-b929-000c29ad1d07,HOF_LAB_SITUATION_ALT2,0,f6cfdb4a-68c6-498e-8695-c417db4712f6
AST,653,e25f7580-1d5f-11e0-b929-000c29ad1d07,HOF_LAB_SITUATION_AST2,0,c3c4b3b3-f874-4968-ae19-0cbe754dc65c
GLUCOSE,887,e24d2ca4-1d5f-11e0-b929-000c29ad1d07,HOF_LAB_SITUATION_Glicemia2,0,7fa6c53c-ca40-4f55-98b5-9dce19426d0c
DATA DE INICIO DO TARV,1190,beac4fb9-e330-4022-b75d-ed5f03fbca98,HOF_TARV_PROPHILAXIS_Patient_Date_Of_Tarv,0,b502f95e-940f-11e9-bc42-526af7764f64
REGIME,1088,27edd246-945d-4234-8767-cefc4a14e03a,HOF_TARV_PROPHILAXIS_Tarv_Initial_Regime,0,b502fba2-941f-11e9-bc42-528af7764f64
ESTA GRAVIDA,1982,e254577c-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_pregnancy,0,a030f9a4-8450-40b3-84d2-e7aa18829a3b
LACTAÇÃO,6332,b18dafe0-9b1c-4a6e-acbe-63dbab86ad10,HOF_CLINICAL_SITUATION_Breastfeeding,0,896f4820-dbd2-11e9-8a34-2a2ae2dbcce4
DATA DE INICIO DA PROFILAXIA COM ISONIAZIDA,6128,78726301-dd4f-4cb3-96d6-ff54a44dfe78,HOF_TARV_PROPHILAXIS_Start_Date_Prophylaxis,8241,2bbc5320-6d9b-45c1-8278-4d4b6bd59623
DATA DE FIM DA PROFILAXIA COM ISONIAZIDA,6129,eaf4d73b-6796-42c6-a017-80043d0ed55d,HOF_TARV_PROPHILAXIS_End_Date_Prophylaxis,8242,8b2c7f10-fa55-44d4-8ddc-91bc5dbd4442
DATA DE INICIO DA PROFILAXIA COM COTRIMOXAZOL,6126,200fd378-962f-433e-8f08-8bcdb0718f47,HOF_TARV_PROPHILAXIS_Start_Date_Prophylaxis,8241,2bbc5320-6d9b-45c1-8278-4d4b6bd59623
DATA DE FIM DA PROFILAXIA COM COTRIMOXAZOL,6127,098c23ae-22ef-4e12-8259-3ed9a84555ab,HOF_TARV_PROPHILAXIS_End_Date_Prophylaxis,8242,8b2c7f10-fa55-44d4-8ddc-91bc5dbd4442
Rastreio de TB,6257,"
",HOF_CLINICAL_SITUATION_TB_Antecedent,0,9c795ff8-db7f-11e9-8a34-2a2ae2dbcce4
DATA DE INICIO DO TRATAMENTO TB,1113,e24fc93c-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_TB_Treatment_Start_Date,0,9c79612e-db7f-11e9-8a34-2a2ae2dbcce4
DATA DE FIM DO TRATAMENTO TB,6120,ff31bb0c-cfe5-4b06-9cc8-e8b8ca677ec9,HOF_CLINICAL_SITUATION_TB_Treatment_End_Date,0,9c79625a-db7f-11e9-8a34-2a2ae2dbcce4
ESTADIO OMS ACTUAL,5356,e24c61c0-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_WHO_Staging,0,1ee08755-f9d1-46ae-b92a-69f52143b763
DATA DE PROXIMA CONSULTA,1410,e24a2bc6-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_Next_Clinical_Visit_Date,0,fccc01be-ded4-11e9-8a34-2a2ae2dbcce4
DATA DO PROXIMO LEVANTAMENTO DE ARV,5096,e2513e84-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_Next_Drug_Pickup_Date,0,fccc02fe-ded4-11e9-8a34-2a2ae2dbcce4
SUBSTITUICAO DE REGIME,1372,e249fd2c-1d5f-11e0-b929-000c29ad1d07,,0,
MUDANCA DE REGIME,1371,e25b58b0-1d5f-11e0-b929-000c29ad1d07,Regime_Change,0,fb3e41a4-db82-11e9-8a34-2a2ae2dbcce4
TRANSFERIDO PARA,1706,e24e2b72-1d5f-11e0-b929-000c29ad1d07,"
",0,"
"
TRANSFERIDO PARA NOME DA UNIDADE SANITARIA,2059,e2569686-1d5f-11e0-b929-000c29ad1d07,"
",0,"
"
ABANDONO,1707,e24e2c58-1d5f-11e0-b929-000c29ad1d07,"
",0,"
"
Yes,1065,e1d81b62-1d5f-11e0-b929-000c29ad1d07,Yes,1,78763e68-104e-465d-8ce3-35f9edfb083d
No,1066,e1d81c70-1d5f-11e0-b929-000c29ad1d07,No,2,f9f633a5-1544-4c44-9394-a7f746a12dff
NO INFORMATION,1457,e1dbff8e-1d5f-11e0-b929-000c29ad1d07,,0,
WHO STAGE 1 ADULT,1204,e1d9055e-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_STAGING_I_CONDITION,0,9c7956c0-db7f-11e9-8a34-2a2ae2dbcce4
WHO STAGE 2 ADULT,1205,e1d9066c-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_STAGING_II_CONDITION,0,9c7957ec-db7f-11e9-8a34-2a2ae2dbcce4
WHO STAGE 3 ADULT,1206,e1d9077a-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_STAGING_III_CONDITION,0,9c795918-db7f-11e9-8a34-2a2ae2dbcce
WHO STAGE 4 ADULT,1207,e1d90888-1d5f-11e0-b929-000c29ad1d07,HOF_CLINICAL_SITUATION_STAGING_IV_CONDITION,0,9c795a4e-db7f-11e9-8a34-2a2ae2dbcce4
INICIO TARV,1256,e24e2ffa-1d5f-11e0-b929-000c29ad1d07,,0,
MANTER,1257,e24e2f0a-1d5f-11e0-b929-000c29ad1d07,,0,
ALTERAR,1259,89ae2d85-8c20-4a13-98bf-8de0ab9355c6,,0,
PARAR TODOS OS MEDICAMENTOS,1260,e240165e-1d5f-11e0-b929-000c29ad1d07,,0,
REINICIAR,1705,e2401834-1d5f-11e0-b929-000c29ad1d07,,0,
SAIDA DE TRATAMENTO ARV,1708,e240191a-1d5f-11e0-b929-000c29ad1d07,,0,
CONTINUA COM INTOLERANCIA,6282,e23f585e-1d5f-11e0-b929-000c29ad1d07,,0,
MUDANCA DE DOSAGEM,981,e24a6aa0-1d5f-11e0-b929-000c29ad1d07,,0,
TDF+3TC+EFV,6324,9dc17c1b-7b6d-488e-a38d-505a7b65ec82,TDF+3TC+EFV,8034,84fb5b4a-8c21-11e9-bc42-526af7764f64
TDF+3TC+NVP,6243,2e44e77e-eac4-4f64-84d2-73d32abf94d5,TDF+3TC+NVP,8035,84fb5d16-8c21-11e9-bc42-526af7764f64
ABC+3TC+EFV,6104,78419317-cdda-42e9-92a3-13cb0cbf0020,ABC+3TC+EFV,8036,84fb5f50-8c21-11e9-bc42-526af7764f64
ABC+3TC+NVP,6105,e11be52e-0da1-4d32-ab5c-e0feb9b6abd6,ABC+3TC+NVP,8052,84fb873c-8c21-11e9-bc42-526af7764f64
AZT+3TC+EFV,1703,e1de19fe-1d5f-11e0-b929-000c29ad1d07,AZT+3TC+EFV,8031,84fb550a-8c21-11e9-bc42-526af7764f64
AZT+3TC+LPV/r,6100,28b28521-b6cd-454e-9ec5-f2c6c9c58468,AZT+3TC+LPV/r,8032,84fb578a-8c21-11e9-bc42-526af7764f64
AZT+3TC+NVP,1651,e1dd2f44-1d5f-11e0-b929-000c29ad1d07,AZT+3TC+NVP,8033,84fb5a00-8c21-11e9-bc42-526af7764f64
D4T 6+3TC+NVP (Triomune Baby),6110,"
",D4T 6+3TC+NVP (Triomune Baby),0,9f729e70-e045-11e9-8a34-2a2ae2dbcce4
D4T+3TC+LPV/r,6103,"
",D4T+3TC+LPV/r,0,9f729cd6-e045-11e9-8a34-2a2ae2dbcce4
D4T+3TC+NVP,792,"
",D4T+3TC+NVP,0,9f72855c-e045-11e9-8a34-2a2ae2dbcce4
D4T+3TC+EFV,1827,"
",D4T+3TC+EFV,0,9f728426-e045-11e9-8a34-2a2ae2dbcce4
D4T+3TC+ABC,6102,"
",D4T+3TC+ABC,0,9f7282fa-e045-11e9-8a34-2a2ae2dbcce4
AZT+3TC+ABC,6116,"
",AZT+3TC+ABC,8051,84fb81c4-8c21-11e9-bc42-526af7764f64
ABC+3TC+LPV/r,6106,"
",ABC+3TC+LPV/r,8040,84fb65f4-8c21-11e9-bc42-526af7764f64
AZT+3TC+LPV/r (2Âª Linha),1314,"
",AZT+3TC+LPV/r,8032,84fb578a-8c21-11e9-bc42-526af7764f64
ABC+3TC+LPV/r (2Âª Linha),1311,"
",ABC+3TC+LPV/r,8040,84fb65f4-8c21-11e9-bc42-526af7764f64
ABC+3TC+NVP (2Âª Linha),1312,"
",ABC+3TC+NVP,8052,84fb873c-8c21-11e9-bc42-526af7764f64
ABC+3TC+EFV (2Âª Linha),1313,"
",ABC+3TC+EFV,8036,84fb5f50-8c21-11e9-bc42-526af7764f64
D4T+3TC+ABC+LPV/r (2Âª Linha),6325,"
",D4T+3TC+ABC+LPV/r,0,9f7281c4-e045-11e9-8a34-2a2ae2dbcce4
AZT+3TC+ABC+LPV/r (2Âª Linha),6326,"
",AZT+3TC+ABC+LPV/r,0,9f72808e-e045-11e9-8a34-2a2ae2dbcce4
D4T+3TC+ABC+EFV (2Âª Linha),6327,"
",D4T+3TC+ABC+EFV,0,9f727f44-e045-11e9-8a34-2a2ae2dbcce4
AZT+3TC+ABC+EFV (2Âª Linha),6328,"
",AZT+3TC+ABC+EFV,0,9f727b52-e045-11e9-8a34-2a2ae2dbcce4
AZT+DDI+LPV/r (2Âª Linha),6109,"
",AZT+DDI+LPV/r,0,9f7278e6-e045-11e9-8a34-2a2ae2dbcce4
TDF+3TC+RAL+DRV/r (3Âª Linha),6329,"
",TDF+3TC+RAL+DRV/r,8048,84fb76fc-8c21-11e9-bc42-526af7764f64
OUTRO,5424,"
",Other__Prophylaxis,8357,c992f904-7bbc-11e9-8f9e-2a86e4085a59
ANEMIA,3,e1cda114-1d5f-11e0-b929-000c29ad1d07,DC_Outras anemias,3996,5a8fe16c-f1c2-4056-8604-ccce0bf74043
DIARREIA,16,e1cdb97e-1d5f-11e0-b929-000c29ad1d07,DC_Diarréia e gastroenterite de origem infecciosa presumível,3682,c54257ac-f7c8-4afc-8d45-bf3985535045
MALNUTRIÇÃO MODERADA SEM RESPOSTA AO TRATAMENTO (P/A 70-79%),68,e1cf1422-1d5f-11e0-b929-000c29ad1d07,DC_Desnutrição protéico-calórica não especificada,4053,97199de6-75b5-459b-82c5-a81a9d59f4e5
MALARIA,123,e1cf5270-1d5f-11e0-b929-000c29ad1d07,DC_Malária não especificada,3804,ccec63ae-265c-4317-9386-f685a622ae26
LEUCEMIA,216,e1d00e18-1d5f-11e0-b929-000c29ad1d07,DC_Leucemia de tipo celular não especificado,3931,acd3b4a9-d209-40b7-bfc4-6ba403fe996c
OTITE EXTERNA,218,e1d0103e-1d5f-11e0-b929-000c29ad1d07,DC_Otite externa,4283,19ebb299-1075-4119-bee2-9c6c9122abd4
SARCOMA DE KAPOSI,507,e1d2984a-1d5f-11e0-b929-000c29ad1d07,DC_Sarcoma de Kaposi,3885,d1e0c78b-7782-47a2-acc1-e21bb5b8c764
FISTULA RECTOVAGINAL,1218,e1d91a3a-1d5f-11e0-b929-000c29ad1d07,DC_Fissura e fístula das regiões anal e retal,4492,8ec0cafc-17d8-489e-9832-6c002c1c17a5
FALTA TERAPUTICA CLINICA,1790,e1de866e-1d5f-11e0-b929-000c29ad1d07,"
",0,"
"
PROLAPSO,2141,e1e117bc-1d5f-11e0-b929-000c29ad1d07,DC_Prolapso genital feminino,4732,4a236992-8cbb-44b2-806d-e9ca581e46bd
POLIPÓ,2142,e1e118b6-1d5f-11e0-b929-000c29ad1d07,DC_Pólipo do trato genital feminino,4735,c02a84c5-cada-47ae-8346-ec12f1ffb54a
ENCEFALOPATIA PROGRESSIVA,5046,e1e2b4be-1d5f-11e0-b929-000c29ad1d07,DC_Outros transtornos do encéfalo,4229,0a8bee87-522b-47dc-a7ac-88ab1e44ab55
FEBRE,5945,e1eafbce-1d5f-11e0-b929-000c29ad1d07,DC_Febre de origem desconhecida,5018,9b4d8b61-b66d-4aff-8b17-c77ef8f1fb91
INTERROMPER,1260,e1d9ee10-1d5f-11e0-b929-000c29ad1d07,,0,
Esquema ARV,1087,,HOF_TARV_PROPHILAXIS_Regime_Change,8247,fb3e41a4-db82-11e9-8a34-2a2ae2dbcce4
Mudanca de Regime,1792,,HOF_TARV_PROPHILAXIS_Change_Motivation,8258,6a7e32a3-88d7-4616-bfc2-88f47fc9e864
Outros diagnósticos,1406,,HOF_CLINICAL_SITUATION_Last_Diagnosis,8328,7bcab5f9-b43a-46ab-ac59-3701c8c76067